About Us

Trade name

OncoTherapy Science, Inc. (OTS)

Address

3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa Prefecture 213-0012, Japan

Tel: 044-820-8251

Fax: 044-820-8260

Foundation

April 6, 2001

Capital

789 Million JPY (Capital surplus 24.7 billion JPY)

Fiscal year end

March

Board Members
President & CEO 
 
Jae-Hyun Park
Chairman 
 
Hatsuo Kato
Director 
 
Su-Youn Chung
Director(External Director) 
 
Toyomasa Katagiri
Director(External Director) 
 
Tomoaki Fujioka
Director(External Director) 
 
Yuichi Komine
Auditor
        
Yuka Yamane
Auditor(External Auditor)
  
Miyako Takagi
Auditor(External Auditor)
  
Teruhisa Tajima

Associated Companies

Subsidiary

Immunas Pharma, Inc.

Business Description

Research and development of antibody drugs

Address

3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa Prefecture 213-0012, Japan

Cancer Precision Medicine, Inc. (CPM)

Business Description

The genome analysis of cancer, liquid biopsy, and development of new immunotherapy including the neoantigen prediction. *

Address

3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa Prefecture 213-0012, Japan

Website

https://www.cancerprecision.co.jp/

*In 2017, OncoTherapy Science, Inc. transferred the function of Tumor Immunology Department (development of cancer immunotherapies, TCR/BCR repertoire analysis) to CPM.

System Requirements

Browsers:Using older browsers, non-compatible browsers or disabling browser features,

such as JavaScript, cookies and SSL, may reduce site functionality.

Supported Browsers

■Windows10

・Microsoft Edge later

・Mozilla Firefox later

・GoogleChrome later

■Mac OS

・Safari later

・GoogleChrome later

・Mozilla Firefox later

back to top